← Browse by Condition
Medical Condition
secondary acute myeloid leukemia
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 2
NCT06928662 Phase 1, Phase 2
Recruiting
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Enrollment
36 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT05807932 Phase 1, Phase 2
Recruiting
Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML
Enrollment
38 pts
Location
Germany
Sponsor
Heinrich-Heine University, Due...
NCT02115295 Phase 2
Recruiting
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
Enrollment
508 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center